Nuwellis (NUWE) Scheduled to Post Quarterly Earnings on Monday

Nuwellis (NASDAQ:NUWE) is set to release its earnings data before the market opens on Monday, November 11th. Analysts expect Nuwellis to post earnings of ($0.88) per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Nuwellis (NASDAQ:NUWE) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($18.85) EPS for the quarter, missing analysts’ consensus estimates of ($9.49) by ($9.36). The business had revenue of $2.19 million for the quarter, compared to the consensus estimate of $1.90 million. Nuwellis had a negative return on equity of 1,716.60% and a negative net margin of 232.24%. On average, analysts expect Nuwellis to post $-10 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Nuwellis Trading Up 2.8 %

NASDAQ NUWE opened at $1.81 on Friday. The firm has a market cap of $3.38 million, a price-to-earnings ratio of -0.01 and a beta of 0.36. The company has a 50 day moving average of $1.49 and a 200-day moving average of $4.03. Nuwellis has a 1-year low of $1.00 and a 1-year high of $31.15.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on NUWE. Roth Capital raised shares of Nuwellis to a “strong-buy” rating in a research report on Monday, July 29th. Roth Mkm reiterated a “buy” rating and set a $17.00 target price on shares of Nuwellis in a research note on Tuesday, August 13th.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.